Basic Information
| LncRNA/CircRNA Name | PCAT29 |
| Synonyms | PCAT29 |
| Region | GRCh38_15:69592200-69695750 |
| Ensemble | ENSG00000259641 |
| Refseq | NR_126437 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR, Western blot etc. |
| Sample | cell lines (VCap, PC3M-luc, LNCaP etc.) |
| Expression Pattern | down-regulated |
| Function Description | This study reveals a novel tumor suppressive locus encoding two hormone-regulated lncRNAs, DRAIC and PCAT30, that are prognostic for a wide variety of cancer types.This study reveals a novel tumor suppressive locus encoding two hormone-regulated lncRNAs, DRAICand PCAT29, that are prognostic for a wide variety of cancer types. |
| Pubmed ID | 25700553 |
| Year | 2015 |
| Title | The lncRNA DRAIC/PCAT29 locus constitutes a tumor suppressive nexus. |
External Links
| Links for PCAT29 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |